Chinese Community Inpatient Thromboembolism

NCT06168331 | Unknown

• 1 other identifier: IIT-2023-0216
• Study Type: observational
• Target: 1,152
• Locations: 1 country
• Sites: 2

Brief Summary

This study is a multicenter cross-sectional study conducted at 20 centers. Data of existing inpatients in 20 community hospitals were collected. Information collected included demographic, co-morbidities, co-medication, laboratory tests, imaging tests, and anticoagulant use. Based on Caprini, Padua, Khorana and PAPT rating tables, VTE risk assessment was carried out for inpatients from 20 community hospitals, and VTE risk stratification of patients and prevention of high-risk VTE patients were analyzed. Blood samples of inpatients were collected to determine coagulation function indicators. VTE screening was performed on hospitalized patients using color Doppler ultrasound to determine the incidence of VTE in community hospitalized patients. On this basis, the predictive efficacy of different VTE risk scores on community hospitalized patients was compared, and a new VTE risk score conforming to community hospitalized patients was constructed.

Conditions

Venous Thromboembolism

Keywords

Venous Thromboembolism; Community hospitalization

Outcome Measures

Primary Outcomes (1)

• Lower extremity venous ultrasound VTE event

  Both lower limb venous B-ultrasonography will be performed on the patients to examine whether the patient has VTE event

  This is a cross-sectional study， patients will be examined Day0 when incorporated into study

Secondary Outcomes (1)

• D-Dimer D-Dimer D-Dimer D-Dimer level

  This is a cross-sectional study， patients will be examined Day0 when incorporated into study

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Inpatients from 20 community health service centers in Shanghai.

You may qualify if:

• Inpatients in community service centers
• Patients or guardians agree with the study plan and sign the informed consent.

You may not qualify if:

• Outpatients in community service centers
• The patient or guardian does not agree to sign the informed consent.

Sponsors & Collaborators

• RenJi Hospital: lead

Study Sites (2)

Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200127, China

ACTIVE NOT RECRUITING

Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200127, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

blood sample

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

Thromboembolism; Embolism and Thrombosis; Vascular Diseases; Cardiovascular Diseases

Central Study Contacts

Meng Hu, PhD

CONTACT

+86 15000090636; humeng@renji.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: associate professor of pharmacy

Study Record Dates

• First Submitted: October 31, 2023
• First Posted: December 13, 2023
• Study Start: October 10, 2023
• Primary Completion: July 1, 2024
• Study Completion: December 31, 2024
• Last Updated: December 13, 2023

Record last verified: 2023-12

Locations

CN (2)